Zymeworks Inc & Jazz Pharmaceuticals PLC - Zanidatamab License and Collaboration Agreement Call Transcript
Thank you for standing by. This is the conference operator. Welcome to Zymeworks zanidatamab Licensing Agreement webcast. (Operator Instructions) And the webcast is being recorded.
I would now like to turn the conference over to Jack Spinks, Head of Investor Relations at Zymeworks. Jack, please go ahead.
Good morning, and welcome, everyone. Thank you for joining. My name is Jack Spinks, Associate Director of Investor Relations here at Zymeworks. Before I turn the call over to Ken, our Chair and CEO, who will speak to you today about this morning's announcement of Zymeworks Licensing and Global Development collaboration with Jazz Pharmaceuticals, I'd like to first briefly remind you that during today's call, we'll be making forward-looking statements.
Forward-looking statements to be identified by words such as should, would, will, continue, may, potential, initiate, look forward to, expect, believe, plan, anticipate, enable and similar words. Forward-looking statements are based upon our current
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |